Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT01574560
Smoking is widely accepted to cause an increase in an individual's likelihood of developing cancer and heart disease. The effects of tobacco smoke are not limited to smokers. Secondhand smoke inhaled by a non-smoker has also been associated with the development of several illnesses. This study focuses on learning how to make your home smoke-free.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Minneapolis, Minnesota, 55455, United States
This study will be conducted in two phases. Phase 1 will be qualitative focus groups/pilot study with the purpose to develop a motivationally enhanced biomarker feedback counseling protocol and all printed materials to be used in Phase 2. After investigators develop a good working treatment protocol, an active intervention in smoking homes who live with a child in their home will be carried out.
Those randomized to the Control Group will receive health education in the form of brochures detailing the health effects of secondhand smoke and how to make their home smoke free. Participants randomized to the Treatment Group will receive tobacco-specific biomarker feedback and personalized motivationally enhanced counseling.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(adult):
Inclusion criteria
(child):
Exclusion criteria
(adult):
Information regarding secondhand smoke and creating a healthy home environment.
Receives brochure and counseling sessions focusing on changing smoking behaviors and/or other health behaviors.
Time frame: From Baseline to Week 26 Follow-Up
Measured by nicotine dosimeter - a passive "badge" hung in the home that measures free floating airborne nicotine particles.
Time frame: From Baseline to Week 26 Follow-Up
Cotinine is an alkaloid found in tobacco and is also a metabolite of nicotine. Cotinine is used as a biomarker for exposure to tobacco smoke. Child (non-smoker) cotinine will be used as an objective measure of secondhand smoke exposure at baseline and again at end of study (week 26).
Time frame: Baseline, Week 16 and Week 26
Measured by mediators and moderators of effect, including psychosocial and tobacco-related variables.
University of Minnesota
Other
Community Outreach and Biomarker Feedback for Smoke-Free Homes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00836199
Behavior, Health Behavior
Tucson, Arizona, United States
View Trial DetailsNCT05952401
Behavior, Chemically-Induced Disorders
St Louis, Missouri, United States
View Trial DetailsNCT04188197
Behavior, Chemically-Induced Disorders
Charlotte, North Carolina, United States
View Trial DetailsNCT04974736
Behavior, Health Behavior
Philadelphia, Pennsylvania, United States
View Trial Details